Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Lok's Laser Microtexturing Wins Clinical Innovations Award At AO.


Business Editors/Health/Medical Writers

DEERFIELD BEACH, Fla.--(BUSINESS WIRE)--April 1, 2004

The first prize for Clinical Innovation Presentations at the recent Annual Meeting of the Academy Of Osseointegration went to Dr Harold Alexander of the Orthogen Corporation, a wholly owned subsidiary Wholly Owned Subsidiary

A subsidiary whose parent company owns 100% of its common stock.

Notes:
In other words, the parent company owns the company outright and there are no minority owners.
 of Bio-Lok International Inc.(OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:BLLI BLLI Broadband Low Layer Information ). The award was given for the presentation "Clinical Evaluation of Laser Microtexturing to Conserve Crestal Bone Around Dental Implants."

The reported results of a prospective, controlled clinical trial controlled clinical trial,
n a research strategy that calls for two samples: an experimental sample of patients receiving a pharmaceutical, and a second sample of control patients receiving a placebo.
 of Bio-Lok's Silhouette Tapered Implants with "Laser-Lok" surface treatment demonstrated the superiority of the implant in retaining crestal bone and establishing a stable soft tissue seal around the implant collar with no increase in plaque or inflammation.

Co-authors of the work are Drs. Gabriele Pecora, Renzo Guarnieri, Rolando Ceccarelli of The Group for Implant Research, Rome, Italy and Dr. John Ricci of the New York University College of Dentistry The New York University College of Dentistry is one of 14 schools and divisions at New York University. The current dean is Dr. Charles N. Bertolami, D.D.S., D.Med. Sc. He was previously the dean of the University of California, San Francisco, School of Dentistry for 12 years. .

Safe Harbor Statement under Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995:

The statements contained in this release, which are not historical facts may be deemed to contain, forward-looking statements, including, but not limited to, deployment of new services, growth of the customer base, and growth of the service area, among other items. Actual results may differ materially from those anticipated in any forward-looking statement with regard to magnitude, timing or other factors. Deviation may result from risk and uncertainties, including, without limitation, the company's dependence on third parties, market conditions for the sale of services, technical factors affecting networks, availability of capital and other risks and uncertainties. The company disclaims any obligation to update information contained in any forward-looking statement.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 1, 2004
Words:266
Previous Article:Diesel ``the Fuel of the Future,'' Navistar CEO Tells Chicago Executives; Calls for government energy policy to encourage greater diesel use.
Next Article:Ethan Allen Unveils an Innovative New Store Design in Knoxville, Tennessee.



Related Articles
Bio-Lok International, Inc. Reports Record Second Quarter and 6 Month Results; Revenues Up 77% and Gross Profit Up 80%.
Bio-Lok International Inc. Reports Second Quarter Results.
TODD-AO HIRES CONSULTANTS FOR POTENTIAL SALE OR MERGER.
LIBERTY TO INVEST IN `POST-HOUSES'.
BioLok Obtains FDA Approval for Silhouette Laser-Lok Dental Implants.
Bio-Lok Completes $3.75 Million Private Placement of Common Stock.
BioLok International Inc. Reports Preliminary 2nd Quarter FY2005 Results: Sales Up Over 38 Percent.
Daniel C. Lubin and Dr. Cary A. Shapoff Elected to Board of Directors of Bio-Lok International; Hollander, Kozak, Smith and Weisman are Re-elected.
Bio-Lok Names Industry Veteran Johnny J. Postell Vice President of U.S. Sales.
Quantum Dot Laser Technology from Fujitsu Laboratories, QD Laser, and University of Tokyo Wins Wall Street Journal Technology Innovation Awards 2006...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles